Joint Commission hosts H1N1 forum
Joint Commission hosts H1N1 forum
The Joint Commission H1N1 forum, a web-based discussion forum, is designed to allow health care organizations to exchange information about the pandemic, innovative solutions, and suggestions that can help other organizations manage patient care during the H1N1 pandemic more effectively.
The Joint Commission has established a web-based discussion forum on H1N1 to allow health care organizations to freely exchange information about the H1N1 pandemic, including innovative solutions they have used and stories of failed attempts that can provide learning experience.
The forum allows peers and experts to share experiences in real time. The H1N1 forum is launched by The Joint Commission with the Centers for Disease Control and Prevention and the Association for Professionals in Infection Control and Epidemiology. Provided as a benefit of accreditation, the forum uses The Joint Com- mission's existing WikiHealthCare platform. Individuals interested in participating in the forum will need to register at wikihealthcare.jointcommission.org/bin/view/Community Post/DiscussionForum.
Participation on the forum will not affect an organization's accreditation. Participants who share examples of their organization's response to the H1N1 pandemic will be asked to provide some basic demographic information, such as organization type and size, but no identifying information about the organization will be requested. The information shared on the forum will be analyzed by The Joint Commission's Division of Quality Measurement and Research for informational purposes and may be used as a resource to share how organizations across the nation respond to challenges related to the H1N1 pandemic.
The Joint Commission H1N1 forum, a web-based discussion forum, is designed to allow health care organizations to exchange information about the pandemic, innovative solutions, and suggestions that can help other organizations manage patient care during the H1N1 pandemic more effectively.Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.